Chris Sale is a serious Cy Young contender. This was once a fairly common combination of words to put together, but after five years of injuries and/or ineffectiveness, it seems like a very weird thing to say today. That’s where we are, though, with Sale striking out 82 batters against 10 walks over his 11 starts and 67 2/3 innings. He leads all NL starters in FIP (2.48), walks per nine innings (1.33), and strikeout-to-walk ratio (8.20); he ranks fourth in strikeouts per nine (10.91), sixth in pitcher WAR (1.9), and 12th in ERA (3.06), though both his excellent FIP and xERA (2.73, third in NL) suggest his actual mark could improve as the season goes on. And for subscribers to the old school, he’s posted an 8-1 record for the Braves, a top contender who lost their ace for the season. Indeed, Atlanta’s offseason gamble to trade for Sale is paying off well so far, and his resurgence have been paramount in preventing the Braves from falling even farther behind the Phillies in the NL East standings.

But what hasn’t been revived yet is any talk about Sale’s chances of making a run at Cooperstown immortality in another decade or so. That’s not surprising, given he lost a good chunk of his mid-career years and stands at only 128 wins and 1,848 1/3 innings — volume that wouldn’t get it done for even the most dominant of starters on a per-inning basis. We’ve long accepted that 300-game winners were going to be increasingly unlikely, but what if 200 becomes the new standard? If Sale truly has reemerged from five years in the injury wasteland, suddenly his Hall of Fame case looks at least plausible.

The 300-win standard never actually was a standard for Hall of Fame voting until relatively recently. Barely a quarter of Hall of Fame pitchers are 300-game winners and a quarter of them (six of 24) exclusively played in the 19th century, when baseball was as much a carnival show as professional sport. From 1917 to 1965, nearly a half-century that included baseball’s peak in the context of American culture, there were never more than three future 300-win pitchers active at any point. In most of those years, baseball had only one or two active pitchers who would eventually hit that threshold, typically a combination of Lefty Grove, Early Wynn, and Warren Spahn. It’s not as if this was an era in baseball history that lacked for Hall of Fame pitchers; slightly more than half of AL/NL Hall of Famers had the majority of their careers within that span of years.

To get a clearer picture, I took all starting pitchers (at least 50% of games as starters) and tracked how many per year got at least 10% support on the BBWAA’s Hall of Fame ballot. It’s not completely an apples-to-apples comparison because the rules have changed at times, but it’s not apples-to-grenades either, as the BBWAA rules have been more stable than the various Veterans Committee schemes.

The stinginess trend toward pitchers is clear. Without a lot of 300-win pitchers to vote on, voters didn’t simply shrug and decide that no pitchers were good enough; they were quite happy to vote for lots of pitchers who failed to get 300 wins, or even 250. From 1936 to 1975, the 10-election rolling average of pitchers with fewer than 200 wins to reach that 10% threshold was 2.5. A pitcher with fewer than 200 wins hasn’t received 10% of the vote since Don Newcombe in 1980. This is despite early voters having the deepest pools of players to vote for; even as Hall of Fame voting started in 1936 and players hung on ballots for 15 years instead of the current 10-year window, voters found room for these pitchers with less impressive win totals.

The 90s cluster of pitching greats are either in the Hall of Fame or off the ballot, so unless voting patterns become more like they were before the 1970s, we may have a real lack of pitchers inducted into the Hall of Fame in the coming years. That process has already started, with only 17 different pitchers ever getting 10% of the vote in 21st-century balloting. There are three active pitchers with 200 wins: Justin Verlander, Max Scherzer, and Clayton Kershaw. There’s also Zack Greinke, who at age 40 has probably thrown his last big league inning, even though he has not yet officially retired and remains unsigned. It seems very likely that all four will get into the Hall of Fame. But then what? Pitcher usage has changed considerably since that quartet debuted. Right now, there are only 11 other active pitchers with 100 (!) career wins, and none between 150 and 200.

Aside from the previously mentioned quartet, only Sale and Gerrit Cole have ever really come up in future Hall of Fame conversations, though Yu Darvish has an interesting-but-tricky case if voters give consideration to his seven years pitching in Japan. For the first time in ZiPS history, ZiPS doesn’t project a single pitcher who hasn’t already eclipsed 200 wins to have at least a 50% shot of reaching the milestone. Considering this, Sale has an fascinating path to the Hall of Fame. For the most part, the writers still aren’t voting for pitchers without lofty win totals, but it has become clear that the fixation on pitcher wins has decreased in Cy Young voting. This could provide an interesting preview of where Hall of Fame voting is going to be over the next 5-10 years, because year-end voters don’t have the same 10-year requirement for BBWAA membership that Hall of Fame voting does. As a result, you tend to get a younger demographic participating in year-end awards voting, and at least some of those writers will be gaining their Hall of Fame vote between now and when Sale hits the ballot. Additionally, some of the most veteran writers aren’t as active in the year-end voting, as some of them are in a state of semi or full retirement but have maintained their Hall vote. In a contrast the younger writers, some of these senior BBWAA members will lose their vote over the next 5-10 years. Call it the Baseball Writing Circle of Life.

Considering this, let’s crank up ZiPS (Hey, you had to know I was going to do this at some point!) and look at Sale’s up-to-date projections. As discussed at the top of this post, Sale has been excellent in 2024 and, just as importantly, he’s been healthy.

Even with ZiPS projecting Sale to be only healthy-ish rather than to have a late-career renaissance like Verlander, that’s another 50 wins and 10 WAR, and with the rest of 2024 added in, 58 wins and 12 WAR. That would bring his total career projection to 186 wins and 62 WAR. Excluding the quartet of Verlander, Scherzer, Kershaw, and Greinke, that’d place Sale second among active pitchers in both wins and WAR, behind only Cole. As far 200 wins go, ZiPS projects Sale to have a 45% chance to reach that milestone, and if 200 becomes the new 300, then he’s got a 45% shot at making it to Cooperstown. Obviously, it’s not that simple, but Sale might not need to get to 200 wins to get elected. When voters look at Sale’s Hall of Fame case, they’ll consider his utter dominance during his best seasons — an eight-season peak from 2012-19 — and, should his health hold up at least to the level that ZiPS projects, he’ll likely go down as one of the very best pitchers during the two-decade era from 2010-2030. That would probably be enough to get him over the hump even if he falls short of 200. This chart tells the story.

It’s not as if Sale’s career is missing those non-statistical highlights. While his postseason performances have been short of cromulence, he does have a World Series ring, six All-Star selections so far, and is already 27th all-time in Cy Young career shares.

Will Sale actually end up in the Hall of Fame? We’ll have to wait until he finishes writing the last handful of chapters, which is sometimes a difficult task. But I think the final story may be better than many people think.

Source